Source: Fox News
Summary
California-based abortion pill suppliers are preparing backup plans in case the Supreme Court restricts access to mifepristone. The Supreme Court is considering whether to limit mailing of the drug, and a lower-court ruling could block telehealth prescriptions and mail distribution of the drug nationwide. Mifepristone is used in nearly two-thirds of all U.S. abortions. California suppliers are pivoting to alternative abortion drugs, such as misoprostol, which is less effective and comes with a higher risk of side effects.
Our Reading
Once again, the discussion returns to a familiar question.
California suppliers are “ready to switch in a day” to alternative abortion drugs. Dr. Michele Gomez, co-founder of the MYA Network, says it’s not going away and it’s not going to slow down. The supply chain pivot is centered on misoprostol, which is used in concert with mifepristone to form the cocktail used in the majority of U.S. abortions. Despite the elevated risk factors, suppliers are ready to ship the backup drug. The MYA Network and the FDA did not immediately respond to comment requests.
It’s a rehearsal for a familiar scenario.
Author: Evan Null
